Jon I. Williams

1.7k total citations
46 papers, 1.1k citations indexed

About

Jon I. Williams is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology and Allergy. According to data from OpenAlex, Jon I. Williams has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Public Health, Environmental and Occupational Health and 14 papers in Immunology and Allergy. Recurrent topics in Jon I. Williams's work include Ocular Surface and Contact Lens (14 papers), Allergic Rhinitis and Sensitization (12 papers) and Mast cells and histamine (9 papers). Jon I. Williams is often cited by papers focused on Ocular Surface and Contact Lens (14 papers), Allergic Rhinitis and Sensitization (12 papers) and Mast cells and histamine (9 papers). Jon I. Williams collaborates with scholars based in United States, United Kingdom and France. Jon I. Williams's co-authors include James E. Cleaver, Michael Zasloff, E C Friedberg, Kenneth J. Holroyd, Mark Donowitz, Michael McLane, Dan Li, Richard J. Pietras, James A. Gow and Shafinaz Akhter and has published in prestigious journals such as Gastroenterology, Biochemistry and Oncogene.

In The Last Decade

Jon I. Williams

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon I. Williams United States	19	645	156	144	131	122	46	1.1k
Uri Nir Israel	21	860 1.3×	57 0.4×	38 0.3×	288 2.2×	182 1.5×	56	1.3k
Qing Sang China	16	475 0.7×	35 0.2×	88 0.6×	306 2.3×	206 1.7×	51	1.2k
Joseph J. Lucas United States	27	983 1.5×	16 0.1×	98 0.7×	148 1.1×	374 3.1×	65	1.8k
Yoshihiro Yasui Japan	17	1.0k 1.6×	17 0.1×	49 0.3×	104 0.8×	287 2.4×	33	1.5k
Tina Cirman Slovenia	5	725 1.1×	29 0.2×	23 0.2×	192 1.5×	99 0.8×	5	1.1k
Helen Turner United States	14	388 0.6×	40 0.3×	274 1.9×	35 0.3×	103 0.8×	20	1.2k
M. Rieber Venezuela	16	550 0.9×	12 0.1×	81 0.6×	126 1.0×	242 2.0×	87	937
Shuraila F. Zerp Netherlands	19	1.0k 1.6×	19 0.1×	19 0.1×	135 1.0×	365 3.0×	28	1.4k
Clifford A. Rinehart United States	20	587 0.9×	15 0.1×	56 0.4×	98 0.7×	126 1.0×	36	1.1k
Roy A. Levine United States	23	1.1k 1.8×	10 0.1×	95 0.7×	216 1.6×	279 2.3×	38	1.7k

Countries citing papers authored by Jon I. Williams

Since Specialization

Citations

This map shows the geographic impact of Jon I. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon I. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon I. Williams more than expected).

Fields of papers citing papers by Jon I. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon I. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon I. Williams. The network helps show where Jon I. Williams may publish in the future.

Co-authorship network of co-authors of Jon I. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Jon I. Williams. A scholar is included among the top collaborators of Jon I. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon I. Williams. Jon I. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vittitow, Jason L. & Jon I. Williams. (2020). Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. Journal of Cataract & Refractive Surgery. 46(8). 1092–1101. 2 indexed citations

Cavet, Megan E., Paul J Gomes, Warner Carr, & Jon I. Williams. (2018). Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis. Journal of Asthma and Allergy. Volume 11. 29–39. 4 indexed citations

Silverstein, Bruce E., et al.. (2018). Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery. Journal of Cataract & Refractive Surgery. 44(10). 1220–1229. 9 indexed citations

Packer, Mark, et al.. (2018). Prospective multicenter clinical trial to evaluate the safety and effectiveness of a new glistening-free one-piece acrylic toric intraocular lens. Clinical ophthalmology. Volume 12. 1031–1039. 13 indexed citations

Torkildsen, Gail, et al.. (2012). Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis. Allergy and Asthma Proceedings. 33(3). 265–274. 8 indexed citations

Williams, Jon I., et al.. (2011). Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 27(4). 385–393. 14 indexed citations

Williams, Jon I., et al.. (2010). Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. Current Medical Research and Opinion. 26(10). 2329–2338. 22 indexed citations

Williams, Jon I., et al.. (2010). Multicenter Clinical Evaluation of Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% to Treat Allergic Conjunctivitis. American Journal of Ophthalmology. 150(1). 122–127.e5. 18 indexed citations

McLaurin, Eugene, et al.. (2009). Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Tearing at 8 Hours Following Dosing in a Multi-Site Clinical Trial Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis. Investigative Ophthalmology & Visual Science. 50(13). 6324–6324. 1 indexed citations

10.

Abelson, Mark B., et al.. (2009). Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Clinical Therapeutics. 31(9). 1908–1921. 32 indexed citations

11.

Torkildsen, Gail, et al.. (2009). Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Ocular Itching in a Clinical Model of Allergic Conjunctivitis. Journal of Allergy and Clinical Immunology. 123(2). S57–S57. 3 indexed citations

12.

Chernova, Marina N., David H. Vandorpe, Jeffrey S. Clark, et al.. (2005). Apparent receptor-mediated activation of Ca²⁺-dependent conductive Cl⁻transport by shark-derived polyaminosterols. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 289(6). R1644–R1658. 5 indexed citations

13.

Higgins, Rosemary D., Yun Yan, Yixun Geng, Michael Zasloff, & Jon I. Williams. (2004). Regression of Retinopathy by Squalamine in a Mouse Model. Pediatric Research. 56(1). 144–149. 21 indexed citations

14.

Peyman, Gholam A., et al.. (2002). EFFECT OF SQUALAMINE ON IRIS NEOVASCULARIZATION IN MONKEYS. Retina. 22(6). 772–778. 26 indexed citations

15.

Li, Dan, Jon I. Williams, & Richard J. Pietras. (2002). Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene. 21(18). 2805–2814. 63 indexed citations

16.

Williams, Jon I., Steven Weitman, Cristina M. González, et al.. (2001). Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.. PubMed. 7(3). 724–33. 56 indexed citations

17.

Sokoloff, Mitchell H., Michael J. Bradley, Haiyen E. Zhau, Jon I. Williams, & Leland W.K. Chung. (1999). SQUALAMINE DOWNREGULATES INTEGRIN alphav beta3 EXPRESSION AND OBLITERATES ADVANCED HUMAN PROSTATE CANCER (HPC). The Journal of Urology. 298–298. 4 indexed citations

18.

Patterson, Thomas E., et al.. (1989). Cloning and expression of a collagen-analog-encoding synthetic gene in Escherichia coli. Gene. 80(2). 305–314. 29 indexed citations

19.

Collins, Micheál, et al.. (1986). Strand displacement applied to assays with nucleic acid probes.. PubMed. 32(9). 1631–6. 21 indexed citations

20.

Williams, Jon I. & James E. Cleaver. (1978). Perturbations in simian virus 40 DNA synthesis by ultraviolet light. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 52(3). 301–311. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact